Immuno-Oncology Biomarkers

Immuno Oncology biomarkers that can be used to identify inflamed tumors that may help to predict a pre-existing antitumor immune response.To identify the Immuno Oncolocgy biomarkers , clarify this unique interplay between the immune system and the tumor, BMS biomarker research is concentrated on 4 types of areas.They are tumor antigens, inflamed tumor markers, immune suppression markers, and host environment factors. Immuno-Oncology (I-O) biomarkers seeks to characterize the relationship between the immune system, the tumor and its microenvironment, and the host. Unique interactions of these factors, as well as Immuno Oncology  biomarker presence and prevalence, contributes to the balance of activation versus suppression of the antitumor immune response.

  • Biomarkers in Immune monitoring
  • Mutation analysis using Biomarkers to guide therapies
  • Cell proliferation Biomarkers
  • Predictive Biomarkers to immunotherapies
  • Biomarkers in Companion Diagnostics
  • Prognostic Biomarkers
  • Liquid Biopsy for Immuno-Oncology
  • Tumor Neoantigens as Biomarker and target identification
  • Biomarkers for combinational immunotherapies
  • Evaluation of Biomarkers in clinical trials
  • Role of Biomarkers in Cancer Vaccines development
  • Tumor Microenvironment profiling
  • Biomarkers for precision immune-oncology
  • Tumor markers in cancer care

Related Conference of Immuno-Oncology Biomarkers

July 15-16, 2019

23rd Global Annual Oncologists Meeting

Yokohama, Japan
July 15-16, 2019

23rd Global Annual Oncologists Meeting

Yokohama, Japan
July 19-20, 2019 |

Women Oncology & Nursing Care

Atlanta, Georgia, USA
September 09-10, 2019

31st International Conference on Cancer Research and Therapy

Zurich,Switzerland
September 13-14, 2019

31st Experts Meet On Cancer Therapy

| Singapore
September 25-26, 2019 |

World Cancer Research and Biomarkers Conference

Toronto, Canada
September 27-28, 2019

Cancer Therapy & Biomarkers

Lisbon, Portugal
October 09-10, 2019

37th World Cancer Conference


Venue: Louis Fitzgerald Hotel
Naas Rd, Newlands Cross
Dublin, D22 X5N7, Ireland
October 9-10, 2019

5th World Congress on Cancer and Diagnostics 2019

Osaka, Japan
October 10-11, 2019 |

International Conference on Cancer Stem Cells

Paris, France

European meet on Cancer Research & Therapy

October 21-22, 2019 Lisbon, Portugal
Oct 21-22, 2019

15th World Congress on Blood Cancer

| Prague, Czech Republic
October 21-22, 2019

4th World Conference on Breast and Cervical Cancer

Helsinki, Finland
October 21-22, 2019

2nd Euro Oncology Summit

Prague | Czech Republic
October 21-22, 2019

4th World Congress on Frontiers in Cancer Research and Therapy

Melbourne, Australia
October 24-25, 2019

3rd International Meeting on Womens Health and Breast Cancer

Auckland, Newzealand
November 11-12 2019

3rd Cancer Diagnostics & Treatment Conference

Frankfurt, Germany
November 18-19, 2019

5th World Congress on Cancer and Diagnostics

Rome, Italy
November 18-19, 2019

World Congress on Women Oncology & Care

Berlin, Germany
November 20-21, 2019

20th Global Cancer Summit

Tokyo, Japan
December 4-5, 2019

Asia Pacific Oncology and Cancer Conference

Tokyo, Japan
February 25-26, 2020

4th Global Summit on Cancer

| Tokyo, Japan
March 09-10, 2020

40th Euro Congress on Cancer Science & Therapy

Rome, Italy
June 22-23, 2020

18th Asia Pacific
Oncologists Annual Meeting

Brisbane, Australia

Immuno-Oncology Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in